8
Oct
2024
![](/46/exhibition/00/05/02/cphi-milan.webp)
SHANXI ZHENDONG MEDPHARM CO.,LTD
Exhibitor at CPHI Milan 2024 stand 14D62, Finished Dosage Formulations
About Us
Categories
-
CN
-
2017On CPHI since
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 14D62, Finished Dosage Formulations
Products Featured at CPHI Milan 2024
-
Product Abiraterone acetate tablets
Abiraterone works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.
Abiraterone is used together with steroid medication (prednisone or methylprednisolone) to treat prostate cancer that has spread to o... -
Product Bicalutamide capsules
50mg daily: Combination with luteinizing hormone releasing hormone (LHRH) analogs or surgical orchiectomy for the treatment of advanced prostatic carcinoma.
150mg daily: For the treatment of patients with locally advanced prostate cancer without distant metastasis, who are unsuitable or unwillin...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance